NO20091231L - Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid - Google Patents

Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid

Info

Publication number: NO20091231L
Authority: NO; Norway
Prior art keywords: ylcarbamoylmethyl; diphenylacetoxy; isoxazol; bicyclo; hydroxy
Prior art date: 2006-08-31

Application number

NO20091231A

Other languages

English (en)

Norwegian (no)

Inventor

Stephanie Monnier

Gerhard Muhrer

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-31

Filing date

2009-03-24

Publication date

2009-03-25

2009-03-24 Application filed by Novartis Ag filed Critical Novartis Ag

2009-03-25 Publication of NO20091231L publication Critical patent/NO20091231L/no

Links

-1 2-hydroxy-2,2-diphenylacetoxy Chemical group 0.000 title 2
BDDIUTHMWNWMRJ-UHFFFAOYSA-N octane;hydrobromide Chemical compound Br.CCCCCCCC BDDIUTHMWNWMRJ-UHFFFAOYSA-N 0.000 title 1
208000027771 Obstructive airways disease Diseases 0.000 abstract 1
BDOZRVOIIAVPMG-GXVQUIFISA-N [(3r)-1-[2-(1,2-oxazol-3-ylamino)-2-oxoethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2,2-diphenylacetate;bromide Chemical compound [Br-].C([C@@H](C(CC1)CC2)OC(=O)C(O)(C=3C=CC=CC=3)C=3C=CC=CC=3)[N+]21CC(=O)NC=1C=CON=1 BDOZRVOIIAVPMG-GXVQUIFISA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)

NO20091231A 2006-08-31 2009-03-24 Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid NO20091231L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06119883A EP1900737A1 (en)	2006-08-31	2006-08-31	Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
PCT/EP2007/007560 WO2008025541A1 (en)	2006-08-31	2007-08-29	Polymorph of (r) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-s-ylcarbamoyl-methyl) -1-azoni a-bicyclo- [2.2.2] octane bromide

Publications (1)

Publication Number	Publication Date
NO20091231L true NO20091231L (no)	2009-03-25

Family

ID=37685707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20091231A NO20091231L (no)	2006-08-31	2009-03-24	Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid

Country Status (21)

Country	Link
US (1)	US20090264461A1 (pt)
EP (2)	EP1900737A1 (pt)
JP (1)	JP2010501611A (pt)
KR (1)	KR20090051110A (pt)
CN (1)	CN101506205A (pt)
AR (1)	AR062582A1 (pt)
AU (1)	AU2007291515A1 (pt)
BR (1)	BRPI0716205A2 (pt)
CA (1)	CA2660983A1 (pt)
CL (1)	CL2007002524A1 (pt)
GT (1)	GT200900044A (pt)
IL (1)	IL196808A0 (pt)
MA (1)	MA31412B1 (pt)
MX (1)	MX2009002300A (pt)
NO (1)	NO20091231L (pt)
PE (1)	PE20080985A1 (pt)
RU (1)	RU2009111390A (pt)
TN (1)	TN2009000069A1 (pt)
TW (1)	TW200817399A (pt)
WO (1)	WO2008025541A1 (pt)
ZA (1)	ZA200900449B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR044134A1 (es) *	2003-05-02	2005-08-24	Novartis Ag	Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
EP2091537B1 (de) *	2006-11-23	2013-05-22	Sinoxa Pharma GmbH	Pharmazeutische zusammensetzungen zur behandlung von kapillarer arteriopathie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR044134A1 (es) *	2003-05-02	2005-08-24	Novartis Ag	Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.

2006
- 2006-08-31 EP EP06119883A patent/EP1900737A1/en not_active Ceased
2007
- 2007-08-28 PE PE2007001164A patent/PE20080985A1/es not_active Application Discontinuation
- 2007-08-29 AR ARP070103830A patent/AR062582A1/es unknown
- 2007-08-29 MX MX2009002300A patent/MX2009002300A/es not_active Application Discontinuation
- 2007-08-29 US US12/438,999 patent/US20090264461A1/en not_active Abandoned
- 2007-08-29 BR BRPI0716205-7A2A patent/BRPI0716205A2/pt not_active Application Discontinuation
- 2007-08-29 JP JP2009525978A patent/JP2010501611A/ja active Pending
- 2007-08-29 CA CA002660983A patent/CA2660983A1/en not_active Abandoned
- 2007-08-29 RU RU2009111390/04A patent/RU2009111390A/ru not_active Application Discontinuation
- 2007-08-29 EP EP07801981A patent/EP2064210A1/en not_active Withdrawn
- 2007-08-29 KR KR1020097006532A patent/KR20090051110A/ko not_active Withdrawn
- 2007-08-29 CN CNA2007800314914A patent/CN101506205A/zh active Pending
- 2007-08-29 WO PCT/EP2007/007560 patent/WO2008025541A1/en not_active Ceased
- 2007-08-29 AU AU2007291515A patent/AU2007291515A1/en not_active Abandoned
- 2007-08-30 TW TW096132302A patent/TW200817399A/zh unknown
- 2007-08-30 CL CL200702524A patent/CL2007002524A1/es unknown
2009
- 2009-01-20 ZA ZA200900449A patent/ZA200900449B/xx unknown
- 2009-01-29 IL IL196808A patent/IL196808A0/en unknown
- 2009-02-27 GT GT200900044A patent/GT200900044A/es unknown
- 2009-02-27 TN TN2009000069A patent/TN2009000069A1/fr unknown
- 2009-03-13 MA MA31715A patent/MA31412B1/fr unknown
- 2009-03-24 NO NO20091231A patent/NO20091231L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1900737A1 (en)	2008-03-19
IL196808A0 (en)	2009-11-18
KR20090051110A (ko)	2009-05-20
WO2008025541A1 (en)	2008-03-06
JP2010501611A (ja)	2010-01-21
AU2007291515A1 (en)	2008-03-06
EP2064210A1 (en)	2009-06-03
AR062582A1 (es)	2008-11-19
CA2660983A1 (en)	2008-03-06
GT200900044A (es)	2012-01-16
ZA200900449B (en)	2010-01-27
TN2009000069A1 (en)	2010-08-19
US20090264461A1 (en)	2009-10-22
PE20080985A1 (es)	2008-09-05
MA31412B1 (fr)	2010-06-01
RU2009111390A (ru)	2010-10-10
MX2009002300A (es)	2009-03-20
BRPI0716205A2 (pt)	2013-11-12
CL2007002524A1 (es)	2008-07-11
TW200817399A (en)	2008-04-16
CN101506205A (zh)	2009-08-12

Legal Events

Date	Code	Title	Description
2011-04-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
WO2006014665A3 (en)	2006-11-16	Arylpyrrolidine derivatives as nk-1/ssri antagonists
MX2007010532A (es)	2007-10-12	Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
NO20083918L (no)	2008-11-12	Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
NO20072978L (no)	2007-06-27	Nye betuinderivater, preparat derav og anvendelse derav
NO20073366L (no)	2007-09-21	1,6-substituert (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-2,5-piperazindionderivater som oksytocinreceptorantagonister for behandling av for tidlige veer, dysmenorri og endometriose
MX2007005644A (es)	2007-06-05	Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de cinasa.
WO2003064387A3 (en)	2004-12-02	Substituted indoles as alpha-1 agonists
NO20043531L (no)	2004-10-25	Indazolforbindelser som er nyttige som proteinkinaseinhibitorer
DK2324008T3 (da)	2012-07-23	Diarylpyrazol som protein kinase inhibitorer
NO20071577L (no)	2007-05-02	Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
NO20073628L (no)	2007-07-16	Pyridoner som er nyttige som inhibitorer av kinaser
MX2010005299A (es)	2010-06-01	Derivados de bis-(sulfonilamino) en terapia 066.
WO2009066152A3 (en)	2009-12-30	Haloallylamine inhibitors of ssao/vap-1 and uses therefor
NO20051100L (no)	2005-05-02	Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
NO20083863L (no)	2008-12-03	Pyrazoler som 11-beta-hsd-1
NO20062691L (no)	2006-09-14	Azabicykliske heterocykler som cannabinoide reseptormodulatorer
WO2007082808A3 (en)	2007-09-13	Thiazoles as 11 beta-hsd1 inhibitors
WO2009155527A3 (en)	2010-06-24	Phosphatidylinositol 3 kinase inhibitors
WO2005075425A3 (en)	2006-12-14	Substituted bisarylurea derivatives as kinase inhibitors
CA2665931C (en)	2014-12-23	Hydrobenzamide derivatives as inhibitors of hsp90
NO20071619L (no)	2007-04-25	Fremgangsmate for fremstilling av indazol forbindelse
WO2008130879A3 (en)	2008-12-18	Tetrahydroindole and tetrahydroindazole derivatives
NO20083836L (no)	2008-11-05	N-hydroksyakrylamidforbindelser
MX2007012212A (es)	2007-12-07	1h-pirazol 4-carboxilamidas, su preparacion y su uso como 11-beta-hidroxiesteroide deshidrogenasa.
NO20082112L (no)	2008-06-23	3-Amino-2-arylpropylazaindoler og deres anvendelse